Recent scientific developments indicate that mRNA technology has transformed the field of vaccine creation, especially in the fight against infectious diseases like COVID-19. mRNA vaccines function by giving cells instructions to generate a protein that sets off an immune response, so teaching the body to identify and fight the virus. This novel strategy is an essential weapon in the toolbox of contemporary medicine against pandemics since it allows for quicker manufacturing times and adaptation to new variations.
Date and Time: November 20th, 2024, 2 PM–3 PM EST
Registration Link:
Dr. Magnus A.G. Hoffmann has been asked by Creative Biolabs to discuss how hybrid mRNA technology is applied in the production of vaccines, how to optimize hybrid mRNA vaccines, and how to employ this technology in the creation of pan-coronavirus vaccines.
In this webinar, we’ll discuss the following important subjects:
An overview of the value of vaccinations in preventing pandemics and the advantages and disadvantages of the existing vaccination approaches, such as mRNA vaccines
An explanation and advancement of the hybrid mRNA technology, which blends aspects of vaccines based on protein nanoparticles and mRNA
hybrid mRNA technology for SARS-CoV-2 in mice evaluated in vivo, with new information on hybrid mRNA-based booster vaccines in animals that had previously received vaccinations
Hybrid mRNA vaccine optimization techniques, including initial findings on novel designs that improve expression
Using hybrid mRNA vaccine technology as a platform for pan-coronavirus vaccination. Don’t miss this opportunity and register now at Creative Biolabs to secure your spot!
